Both in R&D — Physical & Biological Sciences
Medpace Holdings vs Charles River Laboratories International
Over the past year MEDP returned +23.0% and CRL returned +100.4%; their daily moves had a correlation of 0.56.
MEDP +23.0% CRL +100.4%Growth of $1, one year, split-adjusted
| Metric | MEDP | CRL |
|---|---|---|
| Price | $615.94 | $294.59 |
| Market cap | $17.19B | $14.06B |
| Today | −0.48% | +0.60% |
| 1 month | +0.7% | −0.6% |
| 6 months | +36.5% | +85.1% |
| Year to date | +9.7% | +47.7% |
| 1 year | +26.2% | +102.4% |
| Revenue growth (YoY) | +17.2% | −2.7% |
| Gross margin | 28.5% | 36.2% |
| Net margin | 17.2% | −0.1% |
| P/E (TTM) | 35.0× | — |
| Price / sales | 6.2× | 3.5× |
| Net cash | $502.7M | -$2.43B |
| Dividend yield | — | — |
| Volatility (60d) | 37.1% | 39.9% |
| Short % of float | 7.5% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).